I first bought in at .007 after the ordinary lung results. If you ask me what held it back is the shares now on issue and the MC that comes with that.....its why I though management should have explained exactly what we were getting from the SDX deal. Its incredibly complicated, although it was very positive to see the amount of peptides could be lower and keep the results. But like you I think its been slow and too much attention on SDX which I have no doubt Williams and co would have been behind.
I don't think Williams is the white knight. We won't need one if we can get the test up to market. Problem is I think it will be delayed by 12 months at least, mainly due to Covid. I will be watching the quarterly. SDX last quarterly said they expected there to be a drop off in sales.....which were only 94K to end of March. I'm not sure what the lab in Melbourne is doing given the latest trial was done in Geneva and the independent trial will be in Queensland? We have gone from about 700k in wages to over 1.2 million........too top heavy IMO with little income.
BD1 Price at posting:
2.6¢ Sentiment: Hold Disclosure: Held
(20min delay)